[1]胡晓帆 胡咏新** 张会峰 王宏宇 孙凡 林欣雨 孙利.从“治未病”探讨糖尿病视网膜病变中医诊疗思路*[J].现代中医药,2024,(06):036-39.[doi:10.13424/j.cnki.mtcm.2024.06.007]
点击复制

从“治未病”探讨糖尿病视网膜病变中医诊疗思路*()
分享到:

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2024年06期
页码:
036-39
栏目:
出版日期:
2024-11-20

文章信息/Info

文章编号:
1672-0571(2024)04-0036-05
作者:
胡晓帆1 胡咏新2** 张会峰2 王宏宇1 孙凡1 林欣雨2 孙利2
1.南京中医药大学,江苏 南京 210023;2.南京中医药大学附属中西医结合医院,江苏 南京 21002
关键词:
关键词:糖尿病视网膜病变治未病中医治疗防治策略未病先防既病防变瘥后防复
分类号:
R587.2
DOI:
10.13424/j.cnki.mtcm.2024.06.007
文献标志码:
A
摘要:
摘 要:糖尿病视网膜病变(Diabetic retinopathy,DR)是糖尿病所致微血管损害引起的一系列典型病变,中医“治未病”理论是中医预防医学的高度精炼和概括,同样被用于DR的防治。文章结合DR的中医病机演变,重点从“治未病”角度探讨DR不同阶段的防治目标及防治策略,提出未病先防,防止DR的发生,既病防变,延缓DR的进展,瘥后防复,DR术后的预后调护,以期为DR的临床预防和诊疗提供新的思路和理论支持。

参考文献/References:

[1]TEO ZL,THAM YC,YU M,et al.Global prevalence of diabetic retinopathy and projection of burden through 2045:systematic review and meta-analysis[J].Ophthalmology,2021,128(11):1580-1591.
[2]LIU J,HU H,QIU SH,et al.The prevalence and risk factors of diabetic retinopathy:screening and prophylaxis project in 6 provinces of China[J].Diabetes Metab Syndr Obes,2022,15(23):2911-2925.
[3]杨宇琦,秦伟.从肾、从瘀论治糖尿病视网膜病变[J].中国医药科学,2023,13(21):104-107.
[4]仝小林.消渴六论[J].中医杂志,2001,42(4):252-253.
[5]段俊国,金明,接传红,等.糖尿病视网膜病变中医诊疗标准[J].世界中西医结合杂志,2011,6(7):632-637.
[6]倪琳琳,徐云生.糖尿病视网膜病变虚-瘀-痰病机演变及防治思路[J].山东中医药大学学报,2016,40(6):504-506.
[7]袁崇智,徐寒松.浅论糖尿病视网膜病变的中医病机[J].贵阳中医学院学报,2014,36(1):41-43.
[8]接传红.构建病、证、症结合模式下糖尿病视网膜病变辨证论治思维[J].中国中医眼科杂志,2022,32(11):841-845.
[9]张亿,李媛媛,唐雨蕊,等.吴烈教授从痰湿质团体化角度论治糖尿病性视网膜病变经验[J].中国中医眼科杂志,2020,30(3):200-205.
[10]刘星,沈璐,马芳,等.基于“玄府-络脉”理论探讨糖尿病视网膜病变[J].现代中医药,2023,43(6):31-35.
[11]Capacity building for universal eye health coverage in South East Asia beyond 2020[J].Eye,2020,34(7):1262-1270.
[12]蒋鹏飞,彭俊,胡艺,等.眼底病多郁证[J].中医药信息,2020,37(3):97-100.
[13]CUI JIALIN,SHI ENZE,WANG YINGJIE,et al.Network pharmacology study of the mechanism underlying the therapeutic effect of Zhujing pill and its main component oleanolic acid against diabetic retinopathy[J].Biosci Rep,2023,43:undefined.
[14]LIANG DAN,QI YULIN,LIU LU,et al.Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt/HIF-1α pathway[J].Chin Med,2023,18:130.
[15]ZHOU YINI,FAN GUJING,ZHANG YADONG,et al.Identification of Potential Molecular Targets and Active Ingredients of Mingmu Dihuang Pill for the Treatment of Diabetic Retinopathy Based on Network Pharmacology[J].Biomed Res Int,2022,2022:2896185.
[16]张敏芝,高丰.血府逐瘀汤加减治疗糖尿病视网膜病变Ⅳ期疗效及对患者视力水平、生活质量的影响[J].陕西中医.2022,43(10):1400-1403.
[17]苏晓明,张殷建,董志国,等.鳖甲软脉汤治疗中期糖尿病视网膜病变疗效观察[J].现代中西医结合杂志,2022,31(15):2089-2093.
[18]高雅婷.双丹明目胶囊治疗糖尿病视网膜病变研究进展及抗血管内皮生长因子的思考[J].中国民间疗法,2023,31(13):121-125.
[19]孙利,丁永芳.糖可明对糖尿病视网膜病变中血-视网膜屏障的影响[J].南京中医药大学学报,2018,34(4):400-403.
[20]巫其玲.激光光凝术联合中药治疗糖尿病视网膜病变的临床疗效[J].慢性病学杂志,2019,20(11):1739-1740,1743.
[21]WANG LIYUAN,XU JIAYU,YU TIANYANG,et al.Efficacy and safety of curcumin in diabetic retinopathy:A protocol for systematic review and meta-analysis[J].PLoS One,2023,18:e0282866.
[22]MENG FAN,GUO BIN,MA YIQING,et al.Puerarin:A review of its mechanisms of action and clinical studies in ophthalmology[J].Phytomedicine,2022,107:154465.
[23]YAN WEIYING,WANG YAN.Clinical study of Chinese medicine holographic scraping combined with hot ironing in improving early diabetic retinopathy[J].Am J Transl Res,2023,15:511-521.
[24]任彬.中药眼部雾化治疗糖尿病视网膜病变的临床观察[J].当代护士(中旬刊),2019,26(11):90-91.
[25]SUN WU,LI JUNNAN,YAN XIAOLING,et al.Traditional Chinese Medicine Injections for Diabetic Retinopathy:A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials[J].J Integr Complement Med,2022,28:927-939.
[26]余勇军.丹参注射液离子导入联合中药内服治疗糖尿病视网膜病变36例[J].中医外治杂志,2018,27(4):43-44.
[27]郭海叶,陶钧.针刺联合滋阴活血通络方对非增殖期2型糖尿病视网膜病变患者细胞因子 VEGF、IGF-1的作用[J].中医药信息,2019,36(3):42-45.
[28]葛正懿,陈露,罗婷婷,等.中药熏眼联合腧穴按摩在预防糖尿病视网膜病变中的效果观察与护理[J].中西医结合心血管病电子杂志,2018,6(31):100-101.
[29]孙耀成,张珍.滋肝益肾汤联合西药治疗糖尿病视网膜病变玻璃体切除术后临床研究[J].新中医,2023,55(2):85-89.
[30]刘博,来坚,朱琳.清热利湿法治疗糖尿病视网膜病变患者激光术后黄斑水肿的疗效及对视功能、糖代谢、CMT的影响[J].全科医学临床与教育,2023,21(9):801-804.

相似文献/References:

[1]孙林梅 ** 张永丽 刘丹 刘飞虎 ***.“治未病”思想在肛周脓肿防治中的应用[J].现代中医药,2018,(05):093.[doi:10.13424/j.cnki.mtcm.2018.05.031]
[2]李 晶 侯俊明** 罗 璐 江 静 杨得振.基于“治未病冶思想的直肠癌防治探讨[J].现代中医药,2017,(02):068.[doi:10.13424/j.cnki.mtcm.2017.02.027]
[3]梁浩浩 杨利学.中医“治未病”理论在颈肌型颈椎病防治中的应用体会[J].现代中医药,2017,(05):084.[doi:10.13424/j.cnki.mtcm.2017.05.032]
[4]辛 宝.从字说义———治未病学本义及其现代解读[J].现代中医药,2020,(01):018.[doi:10.13424/j.cnki.mtcm.2020.01.004]
 Xin Bao Supervisor: Zhang Dengben.On the Meaning from Words—the Original Meaning and Modern Interpretation of Preventive Treatment of Disease[J].Modern Traditional Chinese Medicine,2020,(06):018.[doi:10.13424/j.cnki.mtcm.2020.01.004]
[5]杨立.“治未病”理论在小儿感冒预防中的应用[J].现代中医药,2020,(02):022.[doi:10.13424/j.cnki.mtcm.2020.02.005]
 Yang Li.Application of the Theory of “ Preventive Treatment of Disease”in the Prevention of Infantile Common Cold[J].Modern Traditional Chinese Medicine,2020,(06):022.[doi:10.13424/j.cnki.mtcm.2020.02.005]
[6]王琨翎子 辛雪红 蒋力生.浅析中医“治未病”理论对围绝经期抑郁症的积极作用[J].现代中医药,2020,(02):026.[doi:10.13424/j.cnki.mtcm.2020.02.006]
[7]滕春凤 陶晓雯 尹倩 辛宝.基于体质的中医香疗在新冠肺炎治疗中的应用思路[J].现代中医药,2020,(05):001.[doi:10.13424/j.cnki.mtcm.2020.05.001]
 Teng Chunfeng,Tao Xiaowen,Yin Qian,et al.A Study on the Application of TCM Aromatherapy in Covid -19 Prevention and Treatment Based on Constitutionology Theory[J].Modern Traditional Chinese Medicine,2020,(06):001.[doi:10.13424/j.cnki.mtcm.2020.05.001]
[8]刘晋利 刘一诚 栾增强 廖静 张艳 阮履强.浅谈新冠肺炎患者“瘥后调理”[J].现代中医药,2021,(01):042.[doi:10.13424/j.cnki.mtcm.2021.01.009]
[9]尹 倩,滕春凤,陶晓雯,等.中药代茶饮在新型冠状病毒肺炎防治中的应用与思考[J].现代中医药,2021,(01):045.[doi:10.13424/j.cnki.mtcm.2021.01.010]
[10]李佳 彭锐.从脾经、肾经论治脊柱疾病的思路探析[J].现代中医药,2021,(03):064.[doi:10.13424/j.cnki.mtcm.2021.03.013]
 LIJia,PENGRui.DiscussiononTheTreatmentofSpinalDiseasesfromTheSpleenMeridianandKidneyMeridian[J].Modern Traditional Chinese Medicine,2021,(06):064.[doi:10.13424/j.cnki.mtcm.2021.03.013]

备注/Memo

备注/Memo:
基金项目:江苏省中医药管理局科技项目(MS2022032)
更新日期/Last Update: 2024-11-21